SSO 2026 Featured Abstracts

Dasatinib reverses myeloid derived suppressor cell (MDSC) inhibition of T-cell proliferation in a triple negative breast cancer model

Presenter: Ian Garbarine, MD

Watch the Recording 

Assessment of Tumor Infiltrating Lymphocyte therapy for metastatic epithelial cancers using Patient Derived Tumor Organoids

Presenter: Alexandra Gustafson, MD

Watch the Recording 

Budget impact of implementing a financial navigation program for cancer patients in Nigeria

Presenter: Segun Afolaranmi, MD, PhD

Watch the Recording 

Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolution

Presenter: Andrew M. Pregnall, MSc, MPhil

Watch the Recording 

Perioperative and volume-based outcomes for hepatic arterial infusion (HAI) pump chemotherapy: a multicenter analysis from the international HAI Consortium Research Network

Presenter: Brittany G. Sullivan, MD

Watch the Recording 

Neoadjuvant Pembrolizumab in Stage IIB/C Melanoma: Updated Clinical Outcomes and Translational Data from Phase 2 Trial NCT03757689

Presenter: M. Saad Farooq, MD, MSTR*

Watch the Recording 

*M. Saad Farooq, MD, MSTR, was unable to present. Giorgos C. Karakousis, MD, presented on his behalf.

Phase II Trial of Systemic Therapy Plus Intraperitoneal (IP) Paclitaxel (PTX) in Gastric/GEJ Cancer Peritoneal Carcinomatosis (GPC)- STOPGAP Trial

Presenter: Maheswari Senthil, MD

Watch the Recording 

Prophylactic lymphovenous bypass at the time of axillary lymph node dissection for lymphedema prevention: A retrospective study of lymphedema rates

Presenter: Lisha Chadda, BA

Watch the Recording

Single-cell RNA sequencing reveals that imatinib alters tumor-associated macrophages in GIST

Presenter: Montana T. Morris, MD

Watch the Recording